According to those opinions, biocidal products used for product-types 1, 5 and 6 containing PHMB (1415; 4.7) may not be expected to satisfy the requirements laid down in Article 19(1)(b) of Regulation (EU) No 528/2012. For those product-types, the scenarios evaluated in the human health and environmental risk assessments identified unacceptable risks.
Recital 5, Decision_act (EU) 2018/619
Judgment of the Court (Eighth Chamber) of 10 November 2022. Laboratoire Pareva v European Commission.Decision
Laboratoire Pareva argues that, moreover, the statement of reasons for the acts at issue cannot be remedied by the reference to one of the recitals of those acts. In that regard, Laboratoire Pareva submits that, in paragraph 80 of the …
10 Nov 2022 · 62021CJ0702
Order of the President of the General Court of 24 August 2018. Laboratoire Pareva and Biotech3D Ltd & Co. KG v European Commission.Decision
Recital 5 of the contested decision states that, according to those opinions, biocidal products used for product-types 1, 5 and 6 containing PHMB (1415; 4.7) may not be expected to satisfy the requirements laid down in Article 19(1)(b) of …
24 Aug 2018 · 62018TO0337